Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesisin vivo

Author:

Reebye Vikash1,Saetrom Pål23,Mintz Paul J.1,Huang Kai-Wen45,Swiderski Piotr6,Peng Ling7,Liu Cheng7,Liu Xiaoxuan7,Lindkaer-Jensen Steen1,Zacharoulis Dimitris8,Kostomitsopoulos Nikolaos9,Kasahara Noriyuki10,Nicholls Joanna P.1,Jiao Long R.1,Pai Madhava1,Spalding Duncan R.1,Mizandari Malkhaz11,Chikovani Tinatin12,Emara Mohamed M.13,Haoudi Abdelali13,Tomalia Donald A.14,Rossi John J.15,Habib Nagy A.1

Affiliation:

1. Department of Surgery and Cancer; Faculty of Medicine; Imperial College London; London UK

2. Department of Cancer Research and Molecular Medicine; Norwegian University of Science and Technology; Trondheim Norway

3. Department of Computer and Information Science; Norwegian University of Science and Technology; Trondheim Norway

4. Department of Surgery & Hepatitis Research Center. National Taiwan University Hospital; National Taiwan University; Taipei City Taiwan

5. Graduate Institute of Clinical Medicine; National Taiwan University; Taipei City Taiwan

6. Department of Molecular Medicine; Beckman Research Institute of the City of Hope; CA USA

7. Centre Interdisciplinaire de Nanoscience de Marseille; Marseille France

8. Department of Surgery; University Hospital of Larissa Mezourlo; Larisa Greece

9. Centre for Experimental Surgery; Biomedical Research Foundation of the Academy of Athens; Athens Greece

10. Department of Medicine; UCLA School of Medicine; Los Angeles CA USA

11. Department of Radiology; Tbilisi 1st Hospital University Clinic. High Technology Medical Center; Tbilisi Georgia

12. Department of Microbiology and Immunology. Faculty of Medicine; Tbilisi State Medical University; Tbilisi Georgia

13. Qatar Biomedical Research Institute; Education City; Doha Qatar

14. Department of Chemistry; University of Pennsylvania; Philadelphia PA USA

15. Division of Molecular Biology; Beckman Research Institute of City of Hope; Duarte CA USA

Publisher

Wiley

Subject

Hepatology

Reference50 articles.

1. Hepatocellular carcinoma: focus on different aspects of management;Waly Raphael;ISRN Oncol,2012

2. Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma;Imai;Clin Transl Oncol,2012

3. Diagnosis and treatment of hepatocellular carcinoma;El-Serag;Gastroenterology,2008

4. The promises and pitfalls of RNA-interference-based therapeutics;Castanotto;Nature,2009

5. Small dsRNAs induce transcriptional activation in human cells;Li;Proc Natl Acad Sci U S A,2006

Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3